Reply To: I refused to be injected with an experimental product

Prof. Shmuel Shapira, former head of the Defense Ministry’s Biological Institute, calls pharma giant’s vaccines ‘mediocre,’ says company only wanted to ‘rake in billions’.

The former head developer of Israel’s experimental coronavirus vaccine lashed out on Wednesday against the decision to award the prestigious Genesis Prize to Pfizer CEO Albert Bourla.

Taking to Twitter, Prof. Shmuel Shapira, the former head of the Defense Ministry’s Israel Institute for Biological Research (IIBR), called the decision “pathetic.”

He also called the pharma giant’s COVID-19 vaccine “mediocre” and effective only in the “short term.”

“There are much more prominent Israeli scientists”.

The CEO’s of these companies did not do this from the goodness of their heart, but merely to rake in billions,” he said. “It is a mediocre vaccine — I was vaccinated three times and got sick. A lot of people got infected after they were vaccinated. Calling the vaccine moderately effective is pretty generous.”

“The bureaucracy has failed us repeatedly.”